U.K. researchers develop experimental HIV vaccine; Pitt researchers target 'alphaviruses' with vaccines;

> the U.K. HIV Vaccine Consortium has developed an experimental HIV vaccine using a similar approach to that used to develop Ebola and malaria vaccines. News

> University of Pittsburgh researchers are working on drugs against "alphaviruses," a group of 30 viruses that are transmitted by mosquitoes. More

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.